Boiron SA (LON:0DTF)

Market Cap	338.19M
Revenue (ttm)	403.20M
Net Income (ttm)	9.37M
Shares Out	n/a
EPS (ttm)	0.54
PE Ratio	36.08
Forward PE	14.37
Dividend	1.01 (4.51%)
Ex-Dividend Date	Jun 3, 2025

Volume	4
Average Volume	88
Open	22.50
Previous Close	n/a
Day's Range	22.50 - 22.50
52-Week Range	22.25 - 33.00
Beta	0.48
RSI	38.98
Earnings Date	Jul 18, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DTF

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial numbers in EUR